Exscientia (NASDAQ: EXAI)
Some price data may be temporarily unavailable.
Exscientia Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Exscientia Company Info
Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.
News & Analysis
Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now
Exscientia has the potential to be a star collaborator and a profitable drug developer, too.
Why Shares of Exscientia Jumped on Wednesday
The company may be riding the wave of an AI healthcare boom.
Why Shares of Exscientia Soared This Week
The company benefited from a surge in interest in AI-associated stocks.
Why Artificial Intelligence Stock Exscientia Leaped 6% Higher Today
With a white-hot technology as a foundation for its business, the biotech's better-than-expected first-quarter results brought about a bull stampede.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.